The Q2 earnings report for Champions Oncology CSBR was released on Wednesday, December 11, 2024 at 04:00 PM.
Here's what investors need to know about the latest announcement.
Earnings
Champions Oncology beat estimated earnings by 400.0%, reporting an EPS of $0.05 versus an estimate of $0.01.
Revenue was up $1.92 million from the same period last year.
Analysis of Past Earnings
During the previous quarter, the company beat on EPS by $0.14, leading to a 10.0% increase share price change the next day.
Here's a look at Champions Oncology's past performance:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.16 | -0.15 | -0.17 |
| EPS Actual | 0.11 | 0.01 | -0.16 | -0.15 |
| Revenue Estimate | 13.23M | 12.69M | 13.48M | 12.84M |
| Revenue Actual | 14.06M | 14.00M | 12.02M | 11.57M |
To track all earnings releases for Champions Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
